As the Delta variant surges in the United States and around the world, we want to reiterate the following statements:

  • Convalescent plasma remains under EUA in the United States.
  • Convalescent plasma is more effective when used early in treatment, research highlighting this can be found here and here
  • Local convalescent plasma is preferable to distantly sourced convalescent plasma.